These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17054668)

  • 1. Reversal of asymptomatic over-anticoagulation with oral vitamin K.
    Chirputkar SK; Poole HJ; McNeil RC; Tansey P; Etherington AM; Morrison C; Tait RC
    Br J Haematol; 2006 Nov; 135(4):591-2. PubMed ID: 17054668
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
    Shetty HG; Backhouse G; Bentley DP; Routledge PA
    Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of warfarin reversal in orthopedic trauma surgery patients.
    Tharmarajah P; Pusey J; Keeling D; Willett K
    J Orthop Trauma; 2007 Jan; 21(1):26-30. PubMed ID: 17211265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative hemostatic management of patients treated with vitamin K antagonists.
    Levy JH; Tanaka KA; Dietrich W
    Anesthesiology; 2008 Nov; 109(5):918-26. PubMed ID: 18946305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
    Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
    Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial.
    Kurnik D; Loebstein R; Rabinovitz H; Austerweil N; Halkin H; Almog S
    Thromb Haemost; 2004 Nov; 92(5):1018-24. PubMed ID: 15543329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 13. Not only green tea but also green leafy vegetables inhibit warfarin.
    Cheng TO
    Int J Cardiol; 2008 Mar; 125(1):101. PubMed ID: 17368832
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols.
    Franco V; Polanczyk CA; Clausell N; Rohde LE
    Am J Med; 2004 May; 116(10):651-6. PubMed ID: 15121490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the effect of anticoagulants on the kidney function].
    Lakin KM; Sergeev LV
    Farmakol Toksikol; 1967; 30(5):626-31. PubMed ID: 4175312
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimisation of the prothrombin complex concentrate dose for warfarin reversal.
    Makris M
    Thromb Res; 2005; 115(6):451-3. PubMed ID: 15792674
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary vitamin K intake and anticoagulation in elderly patients.
    Rohde LE; de Assis MC; Rabelo ER
    Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of various phytonadione (vitamin K1) administration routes in achieving warfarin reversal.
    Laible B
    S D Med; 2007 Apr; 60(4):158-9. PubMed ID: 17555152
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin K and oral anticoagulant drugs as competitive antagonists in man.
    O'Reilly RA
    Pharmacology; 1972; 7(3):149-58. PubMed ID: 5054585
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulants and their reversal.
    Schulman S; Bijsterveld NR
    Transfus Med Rev; 2007 Jan; 21(1):37-48. PubMed ID: 17174219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.